Article Sidebar
Published:
Oct 15, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Effect of combined use of home blood pressure monitoring and nifedipine on blood pressure compliance and quality of life of patients with essential hypertension
Abstract
Purpose: To investigate the effect of combination of home blood pressure monitoring (HBPM) and nifedipine on blood pressure compliance and quality of life in patients with essential hypertension.
Methods: One hundred and twenty essential hypertension patients admitted to Jiaozuo Coal Industry (Group) Co. Ltd Central Hospital from February 2020 to February 2021 were retrospectively studied. They were equally divided into study group (SG) and control group (COG) according to the order of admission. All patients were treated with nifedipine. Blood pressure was regularly measured in COG patients in the consulting room, while for SG patients, blood pressure was measured at home. Treatment compliance, blood pressure-related indices and quality of life of the two groups were determined.
Results: Treatment compliance values of patients in SG at 6 weeks (T2) and 12 weeks (T3) were significantly better than the corresponding values for patients in COG (p < 0.05). The related indices of blood pressure at T2 and T3 were significantly better in SG than in COG (p < 0.05), with higher blood pressure compliance at T2 and T3 in SG (60 and 70 %, respectively) than in COG (p < 0.05). The quality-of-life scores at T3 in SG were significantly higher than those in COG (p < 0.05).
Conclusion: The combined use of HBPM and nifedipine improves treatment compliance, enhances the levels of related indices of blood pressure, increases blood pressure compliance, and quality of life of patients with essential hypertension. Therefore, the combined therapy merits further investigation on a larger scale.
